Summary: The effects of the centrally acting anti cholinesterases tacrine (tetrahydroaminoacridine, THA) and physostigmine (PHY), on local cerebral glucose uti lization (LCGU) have been studied in 27-month-old rats, using the autoradiographic e4Cjdeoxyglucose technique. THA (10 mg/kg i.p.) increased LCGU significantly in 13 of the 54 regions studied (24%) including insular, parietal, temporal, and retrosplenial cortices, septohippocampal system, thalamus, lateral habenula, and superior collicu Ius. In these regions, the average THA-induced increase in LCGU was 24% above control. The whole brain mean LCGU was not significantly increased. PHY (0. 5 mg/kg) increased LCGU in 18% of the regions (average eleva tion, 23%). The whole brain mean LCGU increased byThe centrally acting cholinesterase inhibitor tet rahydroaminoacridine (THA, tacrine) has been re ported to improve cognitive deficits in subpopula tions of Alzheimer's disease (AD) patients. Several multicenter studies (Eagger et aI., 1991; Davis et aI. , 1992; Farlow et aI., 1992; Knapp et aI., 1994) have confirmed the initial positive results of Sum mers (S ummers et aI., 1986). The effects of THA in mildly demented AD patients persist during long term treatment and indicate that THA might not only act on symptoms but also delay the disease process (Nordberg et aI., 1992). The mechanisms mediating the effects of THA are far from clear, but experimental data indicate that THA may produce its therapeutic effects, at least in part, via its action on cholinergic transmission (for review, see Free man and Dawson, 1991). In experimental animals, 1093 7% (p < 0.05). The regional distributions of THA-and PHY-induced increases in LCGU were extremely similar and overlapped the distribution of the M2 muscarinic re ceptors and that of acetylcholinesterase activity, suggest ing that the major effects of THA and PHY on LCGU result from their anticholinesterase action. As compared to those of 3-month-old rats, both the number of regions affected and the amplitude of the metabolic activation were significantly less in aged rats. However, the drugs were still active in old rats and compensated for the age related hypometabolism in some brain areas.